A multicenter protocol to assess the prognostic significance of the tumor microenvironment in patients with squamous cell carcinoma of the larynx.
TILs
laryngeal cancer
laryngectomy
squamous cell carcinoma
tumor microenvironment
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
03 Jul 2024
03 Jul 2024
Historique:
revised:
31
05
2024
received:
20
04
2024
accepted:
25
06
2024
medline:
3
7
2024
pubmed:
3
7
2024
entrez:
3
7
2024
Statut:
aheadofprint
Résumé
The purpose of this multicenter study was to retrospectively investigate the prognostic significance of the tumor microenvironment, in relation to survival in a large cohort of patients with laryngeal squamous cell carcinoma (LSCC), using the method proposed by the International TILs Working Group in breast cancer. All consecutive patients with biopsy-proven LSCC who underwent total laryngectomy (TL) between January 2014 and January 2023 were retrospectively included in the study. A retrospective review of medical records including surgical, pathological and follow-up reports was performed. The density of TILs was determined according to the recommendations of the International TILs Working Group. The study group included 186 patients with LSCC. High TILs were statistically correlated with reduced size and extension of primary tumor (pT stage) with a statistically significant value (S: p = 0.01; P: p = 0.0003) and without needs of salvage therapy (S: p = 0.03; P: p = 0.004). Low TILs were indicative of worse prognosis. Our study confirmed the protective value of TILs and the prognostic role of the tumor microenvironment in LSCC; furthermore, our results showed that the score proposed by the International TILs Working Group for breast cancer can be applied to LSCC.
Sections du résumé
BACKGROUND
BACKGROUND
The purpose of this multicenter study was to retrospectively investigate the prognostic significance of the tumor microenvironment, in relation to survival in a large cohort of patients with laryngeal squamous cell carcinoma (LSCC), using the method proposed by the International TILs Working Group in breast cancer.
METHODS
METHODS
All consecutive patients with biopsy-proven LSCC who underwent total laryngectomy (TL) between January 2014 and January 2023 were retrospectively included in the study. A retrospective review of medical records including surgical, pathological and follow-up reports was performed. The density of TILs was determined according to the recommendations of the International TILs Working Group.
RESULTS
RESULTS
The study group included 186 patients with LSCC. High TILs were statistically correlated with reduced size and extension of primary tumor (pT stage) with a statistically significant value (S: p = 0.01; P: p = 0.0003) and without needs of salvage therapy (S: p = 0.03; P: p = 0.004). Low TILs were indicative of worse prognosis.
CONCLUSIONS
CONCLUSIONS
Our study confirmed the protective value of TILs and the prognostic role of the tumor microenvironment in LSCC; furthermore, our results showed that the score proposed by the International TILs Working Group for breast cancer can be applied to LSCC.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Head & Neck published by Wiley Periodicals LLC.
Références
Cavaliere M, Bisogno A, Scarpa A, et al. Biomarkers of laryngeal squamous cell carcinoma: a review. Ann Diagn Pathol. 2021;54:151787. doi:10.1016/j.anndiagpath.2021.151787
Zhou L, Li Y, Gao W, et al. Assessment of tumor‐associated immune cells in laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2019;145(7):1761‐1772. doi:10.1007/s00432‐019‐02936‐w
Chatzopoulos K, Kotoula V, Manoussou K, et al. Tumor infiltrating lymphocytes and CD8+ T cell subsets as prognostic markers in patients with surgically treated laryngeal squamous cell carcinoma. Head Neck Pathol. 2020;14(3):689‐700. doi:10.1007/s12105‐019‐01101‐6
Lewis JS Jr, Ukpo OC, Ma X‐J, et al. Transcriptionally‐active high‐risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas—a tissue microarray study utilizing E6/E7 mRNA in situ hybridization. Histopathology. 2012;60:982‐991.
Zhang D, Tang D, Heng Y, et al. Prognostic impact of tumor‐infiltrating lymphocytes in laryngeal squamous cell carcinoma patients. Laryngoscope. 2021;131(4):E1249‐E1255. doi:10.1002/lary.29196
Rodrigo JP, Sánchez‐Canteli M, López F, et al. Tumor‐infiltrating lymphocytes in the tumor microenvironment of laryngeal squamous cell carcinoma: systematic review and meta‐analysis. Biomedicine. 2021;9(5):486. doi:10.3390/biomedicines9050486
Mann JE, Smith JD, Birkeland AC, et al. Analysis of tumor‐infiltrating CD103 resident memory T‐cell content in recurrent laryngeal squamous cell carcinoma. Cancer Immunol Immunother. 2019;68(2):213‐220. doi:10.1007/s00262‐018‐2256‐3
Salgado R, Denkert C, Demaria S, et al. International TILs Working Group 2014. The evaluation of tumor‐infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26(2):259‐271. doi:10.1093/annonc/mdu450
Zanoni DK, Patel SG, Shah JP. Changes in the 8th edition of the American Joint Committee on Cancer (AJCC) staging of head and neck cancer: rationale and implications. Curr Oncol Rep. 2019;21(6):52. doi:10.1007/s11912‐019‐0799‐x
Gale N, Poljak M, Zidar N. Update from the 4th edition of the World Health Organization classification of head and neck tumours: what is new in the 2017 WHO blue book for tumours of the hypopharynx, larynx, trachea and parapharyngeal space. Head Neck Pathol. 2017;11(1):23‐32. doi:10.1007/s12105‐017‐0788‐z
Hermanek P, Wittekind C. The pathologist and the residual tumor (R) classification. Pathol Res Pract. 1994;190(2):115‐123. doi:10.1016/S0344‐0338(11)80700‐4
Iseki Y, Shibutani M, Maeda K, et al. A new method for evaluating tumor‐infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H‐E)‐stained tumor sections. PLoS One. 2018;13(4):e0192744. doi:10.1371/journal.pone.0192744
Engblom C, Pfirschke C, Zilionis R, et al. Osteoblasts remotely supply lung tumors with cancer‐promoting SiglecFhigh neutrophils. Science. 2017;358(6367):eaal5081. doi:10.1126/science.aal5081
Vánky F, Klein E, Willems J, et al. Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course. Cancer Immunol Immunother. 1986;21(1):69‐76. doi:10.1007/BF00199380
Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Prognostic value of tumour‐infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol. 1997;182:318‐324.
Borsetto D, Tomasoni M, Payne K, et al. Prognostic significance of CD4+ and CD8+ tumor‐infiltrating lymphocytes in head and neck squamous cell carcinoma: a meta‐analysis. Cancers (Basel). 2021;13(4):781. doi:10.3390/cancers13040781
Heft Neal ME, Smith JD, Birkeland AC, et al. Tumor‐infiltrating lymphocytes in patients with advanced laryngeal cancer undergoing bioselection. Otolaryngol Head Neck Surg. 2022;166(3):498‐505. doi:10.1177/01945998211013765
Hoesli R, Birkeland AC, Rosko AJ, et al. Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma. Oral Oncol. 2018;77:83‐89. doi:10.1016/j.oraloncology.2017.12.003
Wu Z, Li S, Zhu X. The mechanism of stimulating and mobilizing the immune system enhancing the anti‐tumor immunity. Front Immunol. 2021;10(12):682435. doi:10.3389/fimmu.2021.682435